Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia
详细信息    查看全文
文摘

r0005">Prognostic impact of MRD after induction therapy by flow cytometry in 306 AML patients.

r0010">Allogeneic transplantation is better than autologous in patients with MRD > 0.1%.

r0015">MRD has special interest in the intermediate cytogenetic group.

r0020">Scoring system based on MRD and cytogenetics for the prognostic stratification.

NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.